Page last updated: 2024-08-16

succinylcholine and ketorolac

succinylcholine has been researched along with ketorolac in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hobbs, GJ; Leeson-Payne, CG; Nicoll, JM	1
Hooten, WM; Marienau, ME; Petersen, KN; Rasmussen, KG; Ryan, DA; Schroeder, DR; Spackman, TN; Stevens, SR; Sticka, JL; Wieme, LJ; Zosel, JH	1

Reviews

1 review(s) available for succinylcholine and ketorolac

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for succinylcholine and ketorolac

Article	Year
Use of ketorolac in the prevention of suxamethonium myalgia. British journal of anaesthesia, 1994, Volume: 73, Issue:6 Topics: Adolescent; Adult; Analgesics; Atracurium; Female; Follow-Up Studies; Humans; Ketorolac; Male; Middle Aged; Muscular Diseases; Pain; Premedication; Succinylcholine; Tolmetin; Tooth Extraction	1994

Other Studies

2 other study(ies) available for succinylcholine and ketorolac

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Correlates of myalgia in electroconvulsive therapy. The journal of ECT, 2008, Volume: 24, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Ketorolac; Male; Middle Aged; Muscular Diseases; Neuromuscular Depolarizing Agents; Succinylcholine	2008

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011

Correlates of myalgia in electroconvulsive therapy.

The journal of ECT, 2008, Volume: 24, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Ketorolac; Male; Middle Aged; Muscular Diseases; Neuromuscular Depolarizing Agents; Succinylcholine

2008